This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/chebi/
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/mesh/concept/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/wikipedia/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/pdb/
n15http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/pubchem-substance/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02137/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n16http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02137
rdf:type
n5:Drug
n5:description
Absence of molybdenum cofactor leads to accumulation of toxic levels of sulphite and neurological damage usually leading to death within months of birth, due to the lack of active sulfite oxidase.
n5:group
experimental
owl:sameAs
n4:DB02137 n15:DB02137
dcterms:title
Molybdenum Cofactor
adms:identifier
n9:Molybdenum_cofactor n10:DB02137 n11:PCD n12:21437 n13:46936308 n14:46505896
n5:synonym
MoCo
n5:synthesisReference
Guenter Schwarz, Ralf Mendel, Jose Santamaria, Jochen Reiss, "Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency." U.S. Patent US20070037250, issued February 15, 2007.
n16:hasConcept
n17:M0078046
n5:IUPAC-Name
n6:271B414C-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4152-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4151-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B414E-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B414F-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4150-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B414A-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4148-363D-11E5-9242-09173F13E4C5 n6:271B414B-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4149-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4158-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4159-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4153-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4154-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4156-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4155-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4157-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
872689-63-9
n5:Bioavailability
n6:271B415E-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4160-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4161-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B415D-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B415C-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B415F-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B414D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B415A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B415B-363D-11E5-9242-09173F13E4C5